# Protalix BioTherapeutics, Inc.: Form 8-K, filed Aug 15, 2022

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2022-08-15
- Accepted by EDGAR: Aug 15, 2022, 07:04 ET
- Period: 2022-08-15
- Accession: 0001558370-22-013557
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837022013557/plx-20220815x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837022013557/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837022013557/plx-20220815x8k.htm

Filed Aug 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-013557. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
